Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
WHO. Africa - Global Cancer Observatory (GLOBOCAN 2020). 2020.
WHO. Ethiopia - Global Cancer Observatory (GLOBOCAN 2020) 2020 [Available from: https://gco.iarc.fr/today/data/factsheets/populations/231-ethiopia-fact-sheets.pdf.
WHO. Human papillomavirus (HPV) and cervical cancer 11 November 2020 [Available from: https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer.
Castle PE, Einstein MH, Sahasrabuddhe VV. Cervical cancer prevention and control in women living with human immunodeficiency virus. CA: a cancer journal for clinicians. 2021;71(6):505–26.
Chattopadhyay K, Williamson A-L, Hazra A, Dandara C. The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa. BMC Cancer. 2015;15:1–7.
Zhu H, Shen Z, Luo H, Zhang W, Zhu X. Chlamydia trachomatis infection-associated risk of cervical cancer: a meta-analysis. Medicine. 2016;95(13).
Klein C, Kahesa C, Mwaiselage J, West JT, Wood C, Angeletti PC. How the cervical microbiota contributes to cervical cancer risk in sub-Saharan Africa. Front Cell Infect Microbiol. 2020;10:23.
Article PubMed PubMed Central Google Scholar
Muntyanu A, Nechaev V, Pastukhova E, Logan J, Rahme E, Netchiporouk E, et al. Risk factors and communities disproportionately affected by cervical cancer in the Russian Federation: A national population-based study. The Lancet Regional Health-Europe. 2022;20: 100454.
Article PubMed PubMed Central Google Scholar
Zibako P, Tsikai N, Manyame S, Ginindza TG. Cervical cancer management in Zimbabwe (2019–2020). PLoS ONE. 2022;17(9): e0274884.
Article CAS PubMed PubMed Central Google Scholar
Liu Z-C, Liu W-D, Liu Y-H, Ye X-H, Chen S-D. Multiple sexual partners as a potential independent risk factor for cervical cancer: a meta-analysis of epidemiological studies. Asian Pac J Cancer Prev. 2015;16(9):3893–900.
Kashyap N, Krishnan N, Kaur S, Ghai S. Risk factors of cervical cancer: a case-control study. Asia Pac J Oncol Nurs. 2019;6(3):308–14.
Article PubMed PubMed Central Google Scholar
Rahmawati DL, Rahayu DE, Hardjito K. Correlation between Oral Contraceptive Use and the Incidence of Cervical Cancer. Poltekita: Jurnal Ilmu Kesehatan. 2023;16(4):497–504.
Feldman CH, Liu J, Feldman S, Solomon DH, Kim SC. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs. Lupus. 2017;26(7):682–9.
Article CAS PubMed Google Scholar
Lemp JM, De Neve J-W, Bussmann H, Chen S, Manne-Goehler J, Theilmann M, et al. Lifetime Prevalence of Cervical Cancer Screening in 55 Low-and Middle-Income Countries. JAMA. 2020;324(15):1532–42.
Article PubMed PubMed Central Google Scholar
Gelibo T, Roets L, Getachew T, Bekele A. Coverage and factors associated with cervical cancer screening: results from a population-based WHO steps study in Ethiopia. Adv Oncol Res Treat. 2017;1(115):2.
NCDs WT. best buys’ and other recommended interventions for the prevention and control of noncommunicable diseases. Geneva: World Health Organization. 2017.
Organization WH. WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions. 2019.
Federal Ministry of Health E. National Cancer Control Plan of Ethiopia 2016–2020 October 2015 [Available from: https://www.iccp-portal.org/sites/default/files/plans/NCCP%20Ethiopia%20Final%20261015.pdf.
Shiferaw N, Salvador-Davila G, Kassahun K, Brooks MI, Weldegebreal T, Tilahun Y, et al. The single-visit approach as a cervical cancer prevention strategy among women with HIV in Ethiopia: successes and lessons learned. Global Health: Science and Practice. 2016;4(1):87–98.
Kasim J, Kalu A, Kamara B, Alema HB. Cervical Cancer screening service utilization and associated factors among women in the Shabadino District, Southern Ethiopia. Journal of Cancer Epidemiology. 2020;2020.
Nigussie T, Admassu B, Nigussie A. Cervical cancer screening service utilization and associated factors among age-eligible women in Jimma town using health belief model. South West Ethiopia BMC women’s health. 2019;19(1):1–10.
Muluneh BA, Atnafu DD, Wassie B. Predictors of cervical cancer screening service utilization among commercial sex workers in Northwest Ethiopia: a case-control study. BMC Womens Health. 2019;19(1):1–9.
Teame H, Gebremariam L, Kahsay T, Berhe K, Gebreheat G, Gebremariam G. Factors affecting utilization of cervical cancer screening services among women attending public hospitals in Tigray region, Ethiopia, 2018; case control study. PLoS ONE. 2019;14(3): e0213546.
Article PubMed PubMed Central Google Scholar
Aynalem BY, Anteneh KT, Enyew MM. Utilization of cervical cancer screening and associated factors among women in Debremarkos town, Amhara region, Northwest Ethiopia: Community based cross-sectional study. PLoS ONE. 2020;15(4): e0231307.
Article CAS PubMed PubMed Central Google Scholar
Belay Y, Dheresa M, Sema A, Desalew A, Assefa N. Cervical Cancer Screening Utilization and Associated Factors Among Women Aged 30 to 49 Years in Dire Dawa, Eastern Ethiopia. Cancer Control. 2020;27(1):1073274820958701.
Article PubMed PubMed Central Google Scholar
Idowu A, Olowookere SA, Fagbemi AT, Ogunlaja OA. Determinants of cervical cancer screening uptake among women in Ilorin, North Central Nigeria: a community-based study. Journal of cancer epidemiology. 2016;2016.
Mugassa AM, Frumence G. Factors influencing the uptake of cervical cancer screening services in Tanzania: A health system perspective from national and district levels. Nurs Open. 2020;7(1):345–54.
Tigeneh W, Molla A, Abreha A, Assefa M. Pattern of cancer in Tikur Anbessa specialized hospital oncology center in Ethiopia from 1998 to 2010. Int J Cancer Res Mol Mech. 2015;1(1):1.
Binka C, Nyarko SH, Awusabo-Asare K, Doku DT. Barriers to the uptake of cervical cancer screening and treatment among rural women in Ghana. Biomed Res Int. 2019;2019:1–8.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68(6):394–424.
Ncube B, Bey A, Knight J, Bessler P, Jolly PE. Factors associated with the uptake of cervical cancer screening among women in Portland, Jamaica. N Am J Med Sci. 2015;7(3):104.
Article PubMed PubMed Central Google Scholar
Fontham ET, Wolf AM, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA: A Cancer Journal for Clinicians. 2020;70(5):321–46.
Mendes D, Mesher D, Pista A, Baguelin M, Jit M. Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England. The European Journal of Public Health. 2018;28(2):343–7.
Glanz K, Rimer BK, Viswanath K. Health behavior and health education: theory, research, and practice: Wiley; 2008.
Rosenstock IM. Historical origins of the health belief model. Health Educ Monogr. 1974;2(4):328–35.
Federal Democratic Republic of Ethiopia Ministry of Health. Guideline for Cervical Cancer Prevention and Control in Ethiopia. 2015.
Gebreegziabher M, Asefa NG, Berhe S, Factors affecting the practices of cervical cancer screening among female nurses at public health institutions in Mekelle town, Northern Ethiopia,. a cross-sectional study. J Cancer Res. 2014;2016:2016.
Kileo NM, Michael D, Neke NM, Moshiro C. Utilization of cervical cancer screening services and its associated factors among primary school teachers in Ilala Municipality, Dar es Salaam. Tanzania BMC Health Serv Res. 2015;15(1):1–9.
Segni MT, Demissie HF, Tadesse DM, Amdemichael R, Mamo YT, Worku A. Level of knowledge and associated factor toward cervical cancer among women age (21–64) years visiting health facilities in Gulele sub-city Addis Ababa Ethiopia. J Pancreas. 2017;18(1):44–8.
Ibekwe CM, Hoque ME, Ntuli-Ngcobo B. Perceived susceptibility of cervical cancer screening among women attending Mahalapye district hospital. Botswana Southern African J Epidemiol Infect. 2010;25(2):16–21.
LaMorte WW. The Health Belief Model: Behavioral Change Models September 9, 2019 [Available from: https://sphweb.bumc.bu.edu/otlt/mph-modules/sb/behavioralchangetheories/behavioralchangetheories2.html.
Hoque M, Ibekwe C, Ntuli-Ngcobo B. Screening and perceived severity of cervical cancer among women attending Mahalapye District Hospital. Botswana Asian Pacific J Cancer Prev. 2009;10(6):1095–100.
Ibekwe C, Hoque M, Ntuli-Ngcobo B. Perceived benefits of cervical cancer screening among women attending Mahalapye District Hospital. Botswana Asian Pac J Cancer Prev. 2010;11(4):1021–7.
Ibekwe C, Hoque M, Ntuli-Ngcobo B, Hoque M. Perceived barriers of cervical cancer screening among women attending Mahalapye district hospital, Botswana. Arch Clin Microbiol. 2011;2(1):4.
Kibicho JW. Factors influencing utilization of cervical cancer screening services in Embu hospital, Embu county. Kenya: University of Nairobi; 2014.
Bekela E. Assessment of knowledge and attitude of cervical cancer and screening among primary health care workers of West Wollega Zone, Ethiopia, 2016: Addis Ababa University; 2016.
Tadesse A. CKnowledge, attitude and practice (KAP) towards screening for cervical cancer among Adama University female students, Adama, Ethiopia, 2014, 1–58. Recuperado de: http://etd.aau.edu.et/bitstream/123456789/6303/1/Almaz. 2015;20.
Organization WH. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention: World Health Organization; 2013.
Wanyenze RK, Bwanika JB, Beyeza-Kashesya J, Mugerwa S, Arinaitwe J, Matovu JK, et al. Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda. Glob Health Action. 2017;10(1):1380361.
Article PubMed PubMed Central Google Scholar
Ifemelumma C, Anikwe C, Okorochukwu B, Onu F, Obuna J, Ejikeme B, et al. Cervical cancer screening: assessment of perception and utilization of services among health workers in low resource setting. International J Reprod Med. 2019;2019.
Lyimo FS, Beran TN. Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: three public policy implications. BMC Public Health. 2012;12(1):1–8.
Tekle T, Wolka E, Nega B, Kumma WP, Koyira MM. Knowledge, attitude and practice towards cervical cancer screening among women and associated factors in Hospitals of Wolaita Zone. Southern Ethiopia Cancer Manag Res. 2020;12:993.
Getachew S, Getachew E, Gizaw M, Ayele W, Addissie A, Kantelhardt EJ. Cervical cancer screening knowledge and barriers among women in Addis Ababa, Ethiopia. PLoS ONE. 2019;14(5): e0216522.
Article PubMed PubMed Central Google Scholar
Erku DA, Netere AK, Mersha AG, Abebe SA, Mekuria AB, Belachew SA. Comprehensive knowledge and uptake of cervical cancer screening is low among women living with HIV/AIDS in Northwest Ethiopia. Gynecologic Oncol Res Practice. 2017;4(1):1–7.
Ebu NI, Mupepi SC, Siakwa MP, Sampselle CM. Knowledge, practice, and barriers toward cervical cancer screening in Elmina. Southern Ghana Int J Womens Health. 2015;7:31.
Gebru Z, Gerbaba M, Dirar A. Utilization of cervical carcinoma screening service and associated factors among currently married women in Arba Minch Town, Gamo Gofa Zone, Southern Ethiopia 2014.
Chosamata MS, Hong S, Tiraphat S. Determinants of cervical cancer screening utilization among women aged 30–45 years in Blantyre district. Malawi J Public Health Dev. 2015;13(3):19–34.
Bayu H, Berhe Y, Mulat A, Alemu A. Cervical cancer screening service uptake and associated factors among age eligible women in Mekelle Zone, Northern Ethiopia, 2015: a community based study using health belief model. PLoS ONE. 2016;11(3): e0149908.
Article PubMed PubMed Central Google Scholar
Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002;359(9312):1093–101.
留言 (0)